The largest database of trusted experimental protocols

Inveon pet ct multimodality system

Manufactured by Siemens
Sourced in United States

The Inveon PET/CT Multimodality System is a preclinical imaging platform that combines Positron Emission Tomography (PET) and Computed Tomography (CT) technologies. It is designed to enable high-resolution, quantitative, and multimodal imaging of small animals for research purposes.

Automatically generated - may contain errors

25 protocols using inveon pet ct multimodality system

1

In Vivo Imaging of Browning WATs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To activate browning process in WATs, mice were treated with β3 agonist (CL316, 243 Sigma) (1 mg kg−1 BW) daily by intraperitoneal injections for 8 d at RT. Mice PET-CT imaging was performed by Siemens Inveon PET-CT Multimodality System. In brief, mice were fasted overnight, lightly anesthetized using 3% isofluorane, and injected with approximately 150 μCi of 18F-FDG into the tail vein. After that, the animal was permitted to roam freely in the cage for 1 h to uptake 18F-FDG. Subsequently, the animal was placed onto the imaging bed under 2% isofluorane anesthesia for the duration of imaging. All the PET/CT experiments were operated under RT. Tissues of mice after PET/CT imaging were ex vivo measured with γ counter (SN-695 γ RIA Counter) and corrected with tissue weight, respectively.
+ Open protocol
+ Expand
2

Imaging Colitis Inflammation with PET-CT

Check if the same lab product or an alternative is used in the 5 most similar protocols
PET-CT scanning was performed 48 h after colitis induction in selected experiments as described previously (24 (link)) with minor modifications. Briefly, fasted (for 6 h) mice were anesthetized with isoflurane and received 200 µCi [18F]FDG by intraperitoneal (i.p.) injection. One hour later, these mice received 200 µl MD-Gastroview (Mallinckrodt Inc., MO) rectally via a 3.5 French (F) catheter immediately before scan initiation. Computed tomography (CT) scanning was performed for 10 min followed by PET scanning for 20 min using the Inveon PET-CT multimodality system (Siemens). Mice were kept sedated during the scanning process by constant isoflurane inhalation. The images were recorded, and FDG standardized uptake values (SUVs) were analyzed blindly using Inveon Research Workplace software. The MD-Gastroview appears as radiopaque in the CT image, thus highlighting the colon clearly. A region of interest (ROI) comprising the colon was extracted from the CT scan and transferred to the space of the PET scan. Tissues/organs (such as the bladder) other than the colon were excluded from the measurements, and the averages of SUVs of the remaining voxels were calculated to represent the severity of the inflammation.
+ Open protocol
+ Expand
3

PET/CT Imaging of Mice with [18F]FDG

Check if the same lab product or an alternative is used in the 5 most similar protocols
[18F]FDG PET/CT imaging of Balb/c mice was performed using a method described previously [11 (link), 12 (link)]. In short, Balb/c mice were anesthetized by inhalation of 3% isoflurane in 100% oxygen (3 L/min) at room temperature, using an isoflurane vaporizer (Summit Anesthesia Solutions, Salt Lake City, UT) and scanned using a Siemens Inveon PET/CT multimodality system (Siemens Medical Solutions). The mice were transferred to spread-supine position on the imaging bed and subjected to inhalation of 2% isoflurane in 100% oxygen (3 L/min) during the PET/CT procedure. After intravenous injection of [18F]FDG (2 μCi (74 kBq)/g body weight) via tail vein, the mice were subjected to PET/CT imaging at 30 minutes and 2 h post injection (p.i.), respectively. Dynamic whole body data acquisition was started for 30 minutes with the head in the center of the field of view (FOV), followed by static imaging for 15 minutes at 2 h p.i. PET/CT images were reconstructed using the ordered subsets expectation maximization 3D algorithm (OSEM3D), and data were analyzed using the Inveon Research Workplace (IRW) software (Siemens) which allows fusion of CT and PET image volumes.
+ Open protocol
+ Expand
4

FDG-PET/CT Imaging of Mouse Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal protocol related to this study was reviewed and approved by the Institutional Animal Care and Use Committee and Radiation Safety Committee. Mouse FDG-PET/CT imaging was performed using a Siemens Inveon PET/CT Multi-Modality System (Siemens Medical Solutions, Knoxville, TN). All animals were fasted for 12 h prior to FDG-PET imaging. Each mouse received 5.55MBq of FDG in 150 μL saline intravenously via tail vein injection. The mice were placed on a heat pad before and during image acquisition. PET images were acquired 1 h post-injection, for 15 mins, with animals under 2.5% isoflurane. PET images were reconstructed into a single frame using the 3D Ordered Subsets Expectation Maximization (OSEM3D/MAP) algorithm. CT images were acquired immediately after PET. CT projections (360 steps/rotation) were acquired with a power of 80 kVp, current of 500 μA, exposure time of 145 ms, binning of 4, and effective pixel size of 102 μm. PET and CT images were co-registered by the manufacturer’s software. Regions of interest (ROI) were drawn manually over the tumour guided by the corresponding CT images. The target activity was calculated as %ID/g and standardized uptake value (SUV) (Supplementary Table 1).
+ Open protocol
+ Expand
5

Mouse FDG PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse PET/CT imaging was performed using Siemens Inveon PET/CT Multimodality System (Siemens Medical Solutions, Knoxville, TN) with effective spatial resolution of 1.4 mm at the center of field of view (FOV). Mice were fasted for 12 hours prior to PET imaging and each mouse received 140 µCi of FDG in150 µL in saline intravenously via the tail vain. PET images were acquired one hour post-injection. CT images were acquired immediately after PET with the FOV centered at the shoulder of the mouse. CT projections (360 steps/rotation) were acquired with a power of 80 kVp, current of 500 µA, exposure time of 145 ms, binning of 4, and effective pixel size of 102 µm. PET images were reconstructed into a single frame using the 3D Ordered Subsets Expectation Maximization (OSEM3D/MAP) algorithm. The CT reconstruction protocol with a down sample factor of 2, which was set to interpolate bilinearly, used a Shepp-Logan filter. PET and CT images were co-registered by the manufacturer’s software for analysis.
+ Open protocol
+ Expand
6

Imaging Tumor Response to 18F-SynVesT-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The imaging study was started when the tumor size reached 200–500 mm3 on a Inveon PET/CT Multimodality System (Siemens Medical Solutions USA, Inc.,Knoxville, TN, USA). Followed by CT data acquisition, which was conducted at 80 kV and 500 μA with a focal spot of 58 μm, a dynamic scan (0–60 min) was performed immediately after intravenous injection of ~3.5 MBq of 18F-SynVesT-1 in 100 μL saline containing < 5% ethanol into each tumor-bearing mouse under anesthesia, with 2% isoflurane in oxygen. After the dynamic scan, the mouse was allowed to recover in a cage and then re-anesthetized for a 20 min scan at 2.5 and 4 h post-injection (p.i.) (at each time point, n = 3–4). Both CT and PET images were reconstructed with the manufacturer’s software. Reconstructed CT and PET images were fused for quantitative data analysis. Regions of interest (ROIs) were drawn as guided by CT and quantitatively expressed as percent injected dose per gram of tissue (%ID/g).
+ Open protocol
+ Expand
7

PET Imaging of 64Cu-doped Cu(I)-GSH in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The used 64Cu-doped Cu(I)-GSH for PET imaging was synthesized and purified like the previous process with minor modification of adding radioactive 64CuCl2. In vivo mouse imaging was carried out on a Siemens Inveon PET-CT multimodality system (Siemens Medical Solutions, Knoxville, TN, USA) with spatial resolution of ~1.5 mm. 64Cu-doped Cu(I)-GSH was administered to the BALB/c mouse (6–8 weeks) via iv-injection. PET images were collected immediately post injection (p.i.) for 1 h. The CT projections (360/rotation) were conducted with a power of 80 kV(p), current of 500 μA, exposure time of 145 ms, and binning size of 4. The first 1 h PET images were reconstructed into 20 frames of 180 s using a 3D Ordered Subsets Expectation Maximization (OSEM3D/MAP) algorithm. The CT reconstruction protocol used a down sample factor of 2, was set to interpolate bilinearly, and used a Shepp–Logan filter. The PET and CT images were coregistered in Inveon Acquisition Workplace (Siemens Medical Solutions, Knoxville, TN, USA) for analysis. Circular regions of interest (ROI) were drawn manually, encompassing the kidney and bladder in all planes containing the organs. The target activity was calculated as percentage injected dose per gram (%ID/g), which is defined as (activity (mCi/mL))/(total injected dose (mCi))/density (assuming density = 1 g/mL).
+ Open protocol
+ Expand
8

In Vivo Quantification of NHO Volume

Check if the same lab product or an alternative is used in the 5 most similar protocols
NHO volumes were measured in vivo in the Inveon PET-CT multimodality system (Siemens Medical Solutions, Inc.). Mice were anesthetized with a 2% isoflurane oxygen mixture. The parameters used were as follows: 360° rotation, 180 projections, 80 kV voltage, 500 μA current, and effective pixel size 36 μm. After 3D image reconstruction, NHO volume was quantified in the Inveon Research Workplace (Siemens Medical Solutions, Inc.) as previously described.20 (link),42 (link)
+ Open protocol
+ Expand
9

In Vivo Mouse PET/CT Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse PET/CT imaging was performed using a Siemens Inveon PET/CT Multi Modality system (Siemens Medical Solutions, Knoxville, TN) with effective spatial resolution of 1.4 mm at the center of field of view (FOV). All animals were fasted for 12 h prior to PET imaging. Each mouse received 140 μCi of 2-deoxy-2-(18F)fluoro-D-glucose (FDG) in 150 μL in saline intravenously via tail vain injection. The mice were placed on a heat pad before and during image acquisition. PET images were acquired 1h post-injection (p.i.), for 15 min, with animals under 2.5% isoflurane. PET images were reconstructed into a single frame using the 3D Ordered Subsets Expectation Maximization (OSEM3D/MAP) algorithm. CT images were acquired immediately after PET with the FOV centered at the shoulder of the mouse. CT projections (360 steps/rotation) were acquired with a power of 80 kVp, current of 500 μA, exposure time of 145 ms, binning of 4, and effective pixel size of 102 μm. The CT reconstruction protocol used a downsample factor of 2, was set to interpolate bilinearly, and used a Shepp-Logan filter. PET and CT images were co-registered in Inveon Acquisition Workplace (Siemens Medical Solutions) for analysis. Regions of interest (ROI) were drawn manually, encompassing the thyroid in all planes containing the organ. The target activity was calculated as percentage injected dose per gram.
+ Open protocol
+ Expand
10

Prostate Cancer Xenograft PET Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiments were conducted under the protocol approved by the University of Texas Southwestern Institutional Animal Care and Use Committee. PET of athymic nu/nu mice (male; age, 4–5 wks) bearing human prostate cancer xenografts was performed using a Siemens Inveon PET/CT Multimodality System as described previously (16 (link),24 (link)). Briefly, a structural CT scan of tumor-bearing mice was acquired (80 kV, 500 µA) with a pixel size of approximately 0.1 mm to create an anatomic image that was subsequently used for attenuation correction of the PET emission data. After conclusion of the CT scan, mice were injected with the tracer 64CuCl2 (74 kBq or 2 µCi/g of body weight) intravenously via the tail vein. Static whole-body imaging was performed at 2 and 24 h after intravenous injection of the tracer, which consisted of 2 overlapping frames of 15 min for each frame. On completion of the PET/CT at 24 h after injection, a tissue radioactivity assay was performed, and tissue radioactivity was calculated and expressed as decay-corrected percentage injected dose per gram of tissue (%ID/g) as described previously (16 (link)). The size of the postmortem tumors was measured with a caliper, and tumor volumes were calculated using an ellipsoidal formula (1/2 × (length × width2)) modified from that described previously (25 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!